After intrapleural fibrinolysis with alteplase (tissue plasminogen activator, tPA), should the chest catheter be left open?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Chest Catheter After Intrapleural Fibrinolysis

After administering intrapleural fibrinolytic therapy (alteplase, urokinase, or streptokinase), the chest catheter should be clamped for a dwell time of 1-2 hours, then opened to suction drainage—not left continuously open during the treatment period. 1, 2

Standard Post-Fibrinolysis Protocol

The evidence-based approach involves:

  • Clamp the catheter for 60-120 minutes after fibrinolytic instillation to allow the agent adequate contact time with fibrinous septations and loculations 3, 2

  • After the dwell period, open the catheter to suction drainage to evacuate lysed material and fluid 2

  • Repeat this cycle daily for the standard 3-day treatment course recommended by the British Thoracic Society 1

Specific Dosing and Timing Details

The British Thoracic Society protocol specifies:

  • Streptokinase: 250,000 IU in 100 mL normal saline, instilled twice daily, clamped for 6-12 hours between doses 1, 2

  • Urokinase: 100,000 IU in 100 mL normal saline, instilled once daily, clamped for 6-12 hours 1, 2

  • Alteplase: 2-5 mg instilled, clamped for 60-120 minutes (shorter dwell time than other agents) 3

Critical Management Points

Monitor catheter patency before attributing poor drainage to loculations:

  • If the catheter appears blocked, flush with 20-50 mL normal saline before assuming treatment failure 1, 4

  • A blocked catheter should be flushed, not left with fibrinolytic dwelling indefinitely 5

Assess treatment response at 5-8 days after initiating chest tube drainage and fibrinolytic therapy 1, 4

  • Resolution of fever and sepsis indicates successful therapy 1

  • Persistent sepsis despite adequate drainage position (confirmed by CT) indicates treatment failure requiring surgical consultation 4

Common Pitfalls to Avoid

Do not leave the catheter continuously open during fibrinolytic instillation - this defeats the purpose of allowing adequate dwell time for the agent to lyse fibrinous material 2

Do not continue fibrinolytic therapy beyond 3 days without clinical reassessment - the standard course should prompt evaluation for surgical intervention if drainage remains inadequate 1, 4

Do not delay surgical consultation beyond 5-8 days if effective pleural drainage has not been achieved despite fibrinolytic therapy 1, 4

Ensure proper catheter positioning - if CT shows malpositioned tube or undrained loculations, reposition the existing catheter or place additional tubes under image guidance rather than continuing ineffective fibrinolytic therapy 4

Safety Considerations

  • Fever is common, particularly with streptokinase, and does not necessarily indicate treatment failure 1

  • Rare bleeding complications (pleural hemorrhage, epistaxis) can occur, with alteplase showing higher bleeding rates than urokinase in comparative studies 1, 6

  • Patients receiving streptokinase must be given an exposure card and should receive alternative agents (urokinase or alteplase) for any future systemic indications 1

References

Guideline

Intrapleural Fibrinolytic Therapy Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Contrast-Enhanced CT Scan of the Chest

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.